156 related articles for article (PubMed ID: 2854468)
1. Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverine.
Mannhold R
Arzneimittelforschung; 1988 Dec; 38(12):1806-8. PubMed ID: 2854468
[TBL] [Abstract][Full Text] [Related]
2. Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase.
Ronca-Testoni S; Hrelia S; Hakim G; Rossi CA
Experientia; 1985 Jan; 41(1):75-6. PubMed ID: 2981701
[TBL] [Abstract][Full Text] [Related]
3. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
4. Behavioural effects of selective PDE4 inhibitors in relation to inhibition of catalytic activity and competition for [3H]rolipram binding.
Kapui Z; Bence J; Boronkay E; Mikus E; Urbán Szabó K; Baranyi A; Arányi P
Neurobiology (Bp); 1999; 7(1):71-3. PubMed ID: 10746252
[No Abstract] [Full Text] [Related]
5. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
6. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
Stancheva S; Uzunov P; Stoytchev T
Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
8. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity.
Hayashi S; Ozawa H
Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):810-6. PubMed ID: 171085
[No Abstract] [Full Text] [Related]
9. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
[TBL] [Abstract][Full Text] [Related]
10. A structure-activity relationship study on papaverine analogs.
Gupta SP; Garg C; Gupta JK
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):265-8. PubMed ID: 2847262
[TBL] [Abstract][Full Text] [Related]
11. Relationships between structure and vascular activity in a series of benzylisoquinolines.
Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P
Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495
[TBL] [Abstract][Full Text] [Related]
12. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase.
Pöch G; Umfahrer W
Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):257-68. PubMed ID: 183155
[TBL] [Abstract][Full Text] [Related]
14. Role of calcium dependent regulator protein (CDR) in inhibition of 3',5'-c AMP-phosphodiesterase by influenza virus. I. Isolation and purification of CDR and CDR-dependent 3',5'-c' AMP-phosphodiesterase from chick embryos.
Krizanová O; Soláriková L; Hána L
Acta Virol; 1979 Jul; 23(4):295-302. PubMed ID: 40416
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by new anthraquinone compounds, K-259-2 and KS-619-1, of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Matsuda Y; Nakanishi S; Nagasawa K; Kase H
Biochem Pharmacol; 1990 Mar; 39(5):841-9. PubMed ID: 2155616
[TBL] [Abstract][Full Text] [Related]
16. Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3',5'-AMP levels and relaxing effect on rabbit ileum.
Berndt SF; Schulz HU; Stock K
Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep; 294(3):271-5. PubMed ID: 187961
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bovine brain cyclic nucleotide phosphodiesterase by a proteinaceous factor from Escherichia coli.
Iwasa Y
Horm Metab Res; 1982 May; 14(5):265-7. PubMed ID: 6284629
[TBL] [Abstract][Full Text] [Related]
18. Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases.
Sonnenburg WK; Seger D; Kwak KS; Huang J; Charbonneau H; Beavo JA
J Biol Chem; 1995 Dec; 270(52):30989-1000. PubMed ID: 8537356
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
[TBL] [Abstract][Full Text] [Related]
20. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
